1. Home
  2. ALEX vs MESO Comparison

ALEX vs MESO Comparison

Compare ALEX & MESO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALEX
  • MESO
  • Stock Information
  • Founded
  • ALEX 1870
  • MESO 2004
  • Country
  • ALEX United States
  • MESO Australia
  • Employees
  • ALEX N/A
  • MESO N/A
  • Industry
  • ALEX Real Estate Investment Trusts
  • MESO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ALEX Real Estate
  • MESO Health Care
  • Exchange
  • ALEX Nasdaq
  • MESO Nasdaq
  • Market Cap
  • ALEX 1.3B
  • MESO 1.4B
  • IPO Year
  • ALEX N/A
  • MESO N/A
  • Fundamental
  • Price
  • ALEX $17.98
  • MESO $10.53
  • Analyst Decision
  • ALEX Buy
  • MESO Buy
  • Analyst Count
  • ALEX 3
  • MESO 4
  • Target Price
  • ALEX $23.00
  • MESO $18.00
  • AVG Volume (30 Days)
  • ALEX 342.7K
  • MESO 226.8K
  • Earning Date
  • ALEX 07-24-2025
  • MESO 02-26-2025
  • Dividend Yield
  • ALEX 5.00%
  • MESO N/A
  • EPS Growth
  • ALEX 38.72
  • MESO N/A
  • EPS
  • ALEX 0.85
  • MESO N/A
  • Revenue
  • ALEX $236,060,000.00
  • MESO $5,670,000.00
  • Revenue This Year
  • ALEX N/A
  • MESO $178.09
  • Revenue Next Year
  • ALEX $2.06
  • MESO $305.06
  • P/E Ratio
  • ALEX $21.23
  • MESO N/A
  • Revenue Growth
  • ALEX 6.41
  • MESO N/A
  • 52 Week Low
  • ALEX $15.70
  • MESO $5.78
  • 52 Week High
  • ALEX $20.30
  • MESO $22.00
  • Technical
  • Relative Strength Index (RSI)
  • ALEX 62.44
  • MESO 40.75
  • Support Level
  • ALEX $17.58
  • MESO $10.23
  • Resistance Level
  • ALEX $18.06
  • MESO $11.26
  • Average True Range (ATR)
  • ALEX 0.26
  • MESO 0.37
  • MACD
  • ALEX 0.03
  • MESO -0.07
  • Stochastic Oscillator
  • ALEX 87.37
  • MESO 14.29

About ALEX Alexander & Baldwin Inc. REIT Holding Company

Alexander & Baldwin Inc is a Hawaii commercial real estate company. The group owns, operates, and manages million square feet of retail, industrial, and office space in Hawaii. It is a real estate investment trust (REIT) and the owner of grocery and drug-anchored retail centers in the state. It functions through two segments namely Commercial Real Estate and Land Operations. The Commercial Real Estate segment owns and manages retail, industrial spaces, and also urban ground leases in Hawaii, thereby accounting for a majority of the company's revenue. The Land Operations segment actively manages the company's land and real estate-related assets and makes optimum utilization of these assets. Geographically, the activities are carried out across the United States.

About MESO Mesoblast Limited

Mesoblast Ltd is a biotechnology company. It uses its proprietary technology platform to develop and commercialize allogeneic cellular medicines to treat complex diseases resistant to conventional standards of care and where inflammation plays a central role. The company's product candidates include; Ryoncil (remestemcel-L) for the treatment of steroid refractory acute graft versus host disease as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of cell technology platform for commercialization.

Share on Social Networks: